Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 4/20 | 0.43 |
| ▸ | CA1 | P00915 | 4/20 | 0.43 |
| ▸ | CA2 | P00918 | 4/20 | 0.43 |
| ▸ | CA9 | Q16790 | 4/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.43 |
| ▸ | CA7 | P43166 | 3/20 | 0.43 |
| ▸ | AR | P10275 | 2/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.38 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21383209 | 0.94 | EGFR (0.46) | EGFRGABRG2GABRB3GABRA5GABRA1 | |
| SCHEMBL27297567 | 0.86 | GABRG2 (0.44) | EGFRGABRG2GABRB3GABRA5GABRA1 | |
| SCHEMBL31757283 | 0.83 | GABRG2 (0.47) | EGFRGABRG2GABRB3GABRA5GABRA1 | |
| SCHEMBL5619767 | 0.83 | GABRG2 (0.47) | EGFRGABRG2GABRB3GABRA5GABRA1 | |
| SCHEMBL30227090 | 0.82 | CA12 (0.65) | EGFRCA12CA1CA2CA9 | |
| SCHEMBL39335 | 0.82 | CA12 (0.65) | EGFRCA12CA1CA2CA9 | |
| SCHEMBL14344780 | 0.82 | EGFR (0.52) | EGFRCA12CA1CA2CA9 | |
| SCHEMBL31255819 | 0.82 | AR (0.42) | EGFRCA12CA1CA2CA9 | |
| SCHEMBL27006190 | 0.82 | AR (0.42) | EGFRCA12CA1CA2CA9 | |
| SCHEMBL6351877 | 0.81 | GABRG2 (0.43) | EGFRGABRG2GABRB3GABRA5GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111902390-B | Compound, composition, cured product, optically anisotropic body, and reflective film | 富士胶片株式会社 | 2023-08-04 | — | — | CN | disclosed |
| US-11454752-B2 | Optical element, method for forming photo-alignment pattern, and method for manufacturing optical element | FUJIFILM CORPORATION (JP) | 2022-09-27 | — | — | US | disclosed |
| US-11390812-B2 | Compound, composition, cured object, optically anisotropic body, and reflective film | FUJIFILM CORPORATION (JP) | 2022-07-19 | — | — | US | disclosed |
| US-20210002556-A1 | COMPOUND, COMPOSITION, CURED OBJECT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM | FUJIFILM CORPORATION (JP) | 2021-01-07 | — | — | US | disclosed |
| CN-111902390-A | Compound, composition, cured product, optically anisotropic body, and reflective film | 富士胶片株式会社 | 2020-11-06 | — | — | CN | disclosed |
| WO-2020022496-A1 | OPTICAL ELEMENT, METHOD FOR FORMING PHOTO-ALIGNMENT PATTERN, AND METHOD FOR MANUFACTURING OPTICAL ELEMENT | 富士フイルム株式会社 | 2020-01-30 | — | — | WO | disclosed |
| WO-2019182129-A1 | COMPOUND, COMPOSITION, CURED ARTICLE, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM | 富士フイルム株式会社 | 2019-09-26 | — | — | WO | disclosed |
| US-5196422-A | Antiinflammatory agents, antiallergens | ICI PHARMA (FR) | 1993-03-23 | — | — | US | disclosed |
| US-5089513-A | Antiinflammatory agents; antiallergens; asthma; side effect reduction | ICI PHARMA (FR) | 1992-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11390812-B2 | Compound, composition, cured object, optically anisotropic body, and reflective film | MKI67, RB1, FLNA | EGFR 3425/4885GABRG2 3874/4885GABRB3 4112/4885 |
| US-20210002556-A1 | COMPOUND, COMPOSITION, CURED OBJECT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM | MKI67, RB1, FLNA | EGFR 3425/4885GABRG2 3874/4885GABRB3 4112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.